I

Inhalerx Ltd
ASX:IRX

Watchlist Manager
Inhalerx Ltd
ASX:IRX
Watchlist
Price: 0.025 AUD Market Closed
Market Cap: AU$5.3m

Inhalerx Ltd
Investor Relations

InhaleRx Ltd. engages in the development and commercialization of medical technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-01-11. The firm is focused on developing inhaled therapies and medicine delivery systems. The company offers Medihale, an inhaler device with sealed pod designed for use of medical cannabis inhaled formulations. The company utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper proof Medihale Pods provide patients with the additional Medical Cannabis c-liquid security. Its Medihale Starter Kit Pro comes with inhaler battery controller with universal serial bus (USB) charging cable, protective charging case and protective charging case USB charging cable.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Darryl Davies B.Sc.
Chief Executive Officer
No Bio Available
Dr. Robert Jenny B.A., B.Sc., Ph.D.
Chief Scientific Officer
No Bio Available
Mr. Srinivasa Rao Suryadevara
Executive Vice President
No Bio Available
Mr. James Stephen Barrie CPA
Company Secretary & Non-Executive Director
No Bio Available

Contacts

Address
VICTORIA
Melbourne
Suite 103 Level 1, 2 Queen Street
Contacts
+61383955446.0
inhalerx.com.au